Literature DB >> 11284536

Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis.

A J Delima1, T Oates, R Assuma, Z Schwartz, D Cochran, S Amar, D T Graves.   

Abstract

BACKGROUND, AIMS: Periodontal disease is a significant cause of tooth loss among adults and is characterized by the alteration and permanent destruction of the deeper periodontal tissues. Although the presence of pathologic microbes is required to trigger this process, the amplification and progression of the diseased state is believed to rely heavily on the production of host mediators in response to bacteria or their metabolic products. The inflammatory response is effective in preventing large-scale colonization of the gingival tissues by bacteria that lie in close proximity to the tooth surface or within the gingival sulcus. It has been postulated that the host-response in some individuals may lead to an over-reaction to invading oral pathogens resulting in the destruction of periodontal tissues.
METHODS: Several host-derived mediators are believed to contribute to this response. Two agents considered to be essential in periodontal destruction are interleukin-1 (IL-1) and tumor necrosis factor (TNF). We investigated the role of IL-1 and TNF in the loss of connective tissue attachment in a Macaca fascicularis primate model of experimental periodontitis. Silk ligatures impregnated with the periodontal pathogen, Porphyromonas gingivalis were wrapped around the posterior teeth and the activity of IL-1 and TNF were inhibited by soluble receptors to these proinflammatory cytokines via local injection into interdental papillae.
RESULTS: Histomorphometric analysis indicates that IL-1 and TNF antagonists significantly reduced the loss of connective tissue attachment by approximately 51% and the loss of alveolar bone height by almost 91%, both of which were statistically significant.
CONCLUSION: This investigation demonstrates that the loss of connective tissue attachment and progression of periodontal disease can be retarded by antagonists to specific host mediators such as IL-1 and TNF and may provide a potential treatment modality to combat the disease process.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11284536     DOI: 10.1034/j.1600-051x.2001.028003233.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  58 in total

Review 1.  Periodontitis: a polymicrobial disruption of host homeostasis.

Authors:  Richard P Darveau
Journal:  Nat Rev Microbiol       Date:  2010-07       Impact factor: 60.633

2.  The silencing of cathepsin K used in gene therapy for periodontal disease reveals the role of cathepsin K in chronic infection and inflammation.

Authors:  W Chen; B Gao; L Hao; G Zhu; J Jules; M J MacDougall; J Wang; X Han; X Zhou; Y-P Li
Journal:  J Periodontal Res       Date:  2016-01-11       Impact factor: 4.419

3.  Induction of M2 Macrophages Prevents Bone Loss in Murine Periodontitis Models.

Authors:  Z Zhuang; S Yoshizawa-Smith; A Glowacki; K Maltos; C Pacheco; M Shehabeldin; M Mulkeen; N Myers; R Chong; K Verdelis; G P Garlet; S Little; C Sfeir
Journal:  J Dent Res       Date:  2018-11-04       Impact factor: 6.116

4.  The association between periodontal disease and joint destruction in rheumatoid arthritis extends the link between the HLA-DR shared epitope and severity of bone destruction.

Authors:  H Marotte; P Farge; P Gaudin; C Alexandre; B Mougin; P Miossec
Journal:  Ann Rheum Dis       Date:  2005-11-10       Impact factor: 19.103

Review 5.  Novel host response therapeutic approaches to treat periodontal diseases.

Authors:  Keith L Kirkwood; Joni A Cirelli; Jill E Rogers; William V Giannobile
Journal:  Periodontol 2000       Date:  2007       Impact factor: 7.589

6.  Abundant secretion of bioactive interleukin-1beta by human macrophages induced by Actinobacillus actinomycetemcomitans leukotoxin.

Authors:  P Kelk; R Claesson; L Hänström; U H Lerner; S Kalfas; A Johansson
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

7.  Effects of etanercept, a tumour necrosis factor-alpha antagonist, in an experimental model of periodontitis in rats.

Authors:  R Di Paola; E Mazzon; C Muià; C Crisafulli; D Terrana; S Greco; D Britti; D Santori; G Oteri; G Cordasco; S Cuzzocrea
Journal:  Br J Pharmacol       Date:  2007-01-02       Impact factor: 8.739

Review 8.  The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders.

Authors:  H E Barksby; S R Lea; P M Preshaw; J J Taylor
Journal:  Clin Exp Immunol       Date:  2007-06-21       Impact factor: 4.330

9.  A Dual Role for P2X7 Receptor during Porphyromonas gingivalis Infection.

Authors:  E S Ramos-Junior; A C Morandini; C L C Almeida-da-Silva; E J Franco; J Potempa; K A Nguyen; A C Oliveira; D S Zamboni; D M Ojcius; J Scharfstein; R Coutinho-Silva
Journal:  J Dent Res       Date:  2015-07-07       Impact factor: 6.116

Review 10.  Macrophage immunomodulation in chronic osteolytic diseases-the case of periodontitis.

Authors:  Corneliu Sima; Ana Viniegra; Michael Glogauer
Journal:  J Leukoc Biol       Date:  2018-11-19       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.